[
    [
        {
            "time": "2021-08-13",
            "original_text": "长春高新：子公司拟受让宁波熙健所拥有的EG017相关知识产权及专有权项目",
            "features": {
                "keywords": [
                    "长春高新",
                    "子公司",
                    "宁波熙健",
                    "EG017",
                    "知识产权",
                    "专有权"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "长春高新：子公司拟受让宁波熙健所拥有的EG017相关知识产权及专有权项目",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-13",
            "original_text": "长春高新(000661.SZ)：子公司拟引进上海盖浦生物一种白介素-2突变体专利技术实施许可权利",
            "features": {
                "keywords": [
                    "长春高新",
                    "子公司",
                    "上海盖浦生物",
                    "白介素-2",
                    "专利技术",
                    "实施许可"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "长春高新(000661.SZ)：子公司拟引进上海盖浦生物一种白介素-2突变体专利技术实施许可权利",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-13",
            "original_text": "长春高新上半年实现营收49.63亿元",
            "features": {
                "keywords": [
                    "长春高新",
                    "上半年",
                    "营收",
                    "49.63亿元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新上半年实现营收49.63亿元",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-13",
            "original_text": "百克生物：百益制药解散并清算",
            "features": {
                "keywords": [
                    "百克生物",
                    "百益制药",
                    "解散",
                    "清算"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "百克生物：百益制药解散并清算",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-13",
            "original_text": "长春高新业绩增速放缓，“顶流”基金经理葛兰增持社保基金减持",
            "features": {
                "keywords": [
                    "长春高新",
                    "业绩增速",
                    "葛兰",
                    "增持",
                    "社保基金",
                    "减持"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "长春高新业绩增速放缓，“顶流”基金经理葛兰增持社保基金减持",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-13",
            "original_text": "长春高新上半年净利润同比增长46.85%，明星基金经理葛兰二季度增持42万股",
            "features": {
                "keywords": [
                    "长春高新",
                    "上半年",
                    "净利润",
                    "同比增长",
                    "46.85%",
                    "葛兰",
                    "增持"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新上半年净利润同比增长46.85%，明星基金经理葛兰二季度增持42万股",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-13",
            "original_text": "长春高新半年度归母净利同比增46.85%至19.23亿元",
            "features": {
                "keywords": [
                    "长春高新",
                    "半年度",
                    "归母净利",
                    "同比增",
                    "46.85%",
                    "19.23亿元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "长春高新半年度归母净利同比增46.85%至19.23亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]